Medically reviewed by Qin Rao, MD Hepatitis A is a temporary liver infection caused by the hepatitis A virus. Symptoms include diarrhea, dark urine, fatigue, fever, nausea, vomiting, pain, and ...

Further data could back zanidatamab as advanced treatment for HER2-positive advanced gastroesophageal adenocarcinoma.

Panelists discuss how comprehensive patient education about expected adverse effects, combined with prophylactic measures ...

Extended oral antibiotic prophylaxis eliminated UTIs after robot-assisted radical cystectomy procedures. Prophylactic ...

The FDA has approved garadacimab-gxii for prophylactic use in patients aged 12 years and older with hereditary angioedema, ...

Vancomycin appeared to top placebo for lowering Clostridioides difficile infection (CDI) recurrence rates in patients taking ...

A panelist discusses the evolving role of prophylactic tocilizumab in reducing cytokine release syndrome during bispecific ...

The BASIS trial demonstrated that prophylactic treatment with HYMPAVZI resulted in a statistically significant and clinically relevant reduction in annualized bleeding rate (ABR) of treated bleeds in ...

In those patients, preventive treatment with Hympavzi led to significant reductions in annualized bleed rates compared with on-demand and prophylactic treatment with standard replacement therapy. The ...

The BASIS trial demonstrated that prophylactic treatment with HYMPAVZI resulted in a statistically significant and clinically relevant reduction in annualized bleeding rate (ABR) of treated bleeds ...

Is it optimal to treat patients with cirrhosis with lactulose in order to prevent hepatic encephalopathy? This new study investigates the best treatment options.

Objectives To develop EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in patients with autoimmune inflammatory rheumatic diseases (AIIRD). Methods An ...